Skip to main content
B-Soft Co.,Ltd logo

B-Soft Co.,Ltd — Investor Relations & Filings

Ticker · 300451 ISIN · CNE100001ZG7 LEI · 300300MFQ9JA2GF0EE07 Shenzhen Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,813 across all filing types
Latest filing 2020-09-25 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300451

About B-Soft Co.,Ltd

https://www.bsoft.com.cn

B-Soft Co.,Ltd. specializes in the development and implementation of comprehensive healthcare informatics solutions. The company provides a wide range of software products and technical services designed to facilitate the digital transformation of medical institutions and public health systems. Its core portfolio includes Hospital Information Systems (HIS), Electronic Medical Records (EMR), Laboratory Information Systems (LIS), and Radiology Information Systems (RIS). B-Soft also develops integrated regional health information platforms and smart medical solutions that leverage big data and artificial intelligence to improve clinical efficiency and patient care management. The company focuses on delivering scalable, interoperable systems that support the modernization of healthcare infrastructure, catering to hospitals, community health centers, and government health administrative departments.

Recent filings

Filing Released Lang Actions
关于对2019年限制性股票激励计划部分限制性股票回购注销的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the repurchase and cancellation of part of its restricted stock incentive plan shares. It details board and supervisory approvals, legal opinions, and the impact on share capital. The content focuses on a specific corporate action related to stock incentives, including the number of shares repurchased and cancelled, reasons for the cancellation, and compliance with relevant laws and regulations. It is not a full financial report, earnings release, or management discussion, nor is it a general regulatory filing or a report publication announcement. The document fits the category of a Capital/Financing Update (CAP) because it concerns changes in the company's capital structure through repurchase and cancellation of shares under a stock incentive plan.
2020-09-25 Chinese
关于董事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election and nomination of the company's new board of directors. It details the candidates for the seventh board, their qualifications, shareholdings, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is 4359 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is MANG with high confidence.
2020-09-25 Chinese
独立董事提名人声明
Board/Management Information Classification · 95% confidence The document is a public statement from the board of directors nominating an individual as an independent director candidate. It contains detailed declarations about the nominee's qualifications, compliance with various regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically about a director nomination. This fits the category of Board/Management Information (MANG). The document length is about 5080 characters, which is sufficient for a detailed nomination statement rather than a brief announcement or certification.
2020-09-25 Chinese
独立董事候选人声明
Regulatory Filings Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for serving as an independent director. It includes statements about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no report of financial performance, no voting results, no management changes, no earnings information, and no mention of any report publication or announcement. The document is a formal declaration related to governance and regulatory compliance for board membership. This type of document fits best under Regulatory Filings (RNS), as it is a compliance-related filing that does not fit into other specific categories such as Board/Management Information (MANG) or Governance Information (CGR) which typically cover broader governance reports or announcements of board changes. Therefore, the classification is RNS with high confidence.
2020-09-25 Chinese
独立董事候选人声明
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for serving as an independent director. It includes statements about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no report of financial performance, no voting results, no management changes, no earnings information, and no mention of any report publication. The document is a formal declaration related to board/management information, specifically concerning the appointment or candidacy of an independent director. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (5119 characters) supports it being a full declaration rather than a brief announcement or certification.
2020-09-25 Chinese
北京市天元律师事务所关于公司2019年限制性股票激励计划相关调整事项及回购注销部分限制性股票的法律意见
Regulatory Filings Classification · 95% confidence The document is a legal opinion issued by a law firm regarding adjustments and repurchase/cancellation of restricted stock under a 2019 stock incentive plan of a company. It references specific board and shareholder meetings approving these adjustments and repurchases. The document is a standalone legal opinion related to a stock incentive plan adjustment and repurchase, not a full annual or interim financial report, earnings release, or other financial filing. It does not contain financial statements or earnings data but is a legal advisory document. This fits best under the category of Regulatory Filings (RNS), which covers miscellaneous filings that do not fit other categories, including legal opinions related to corporate actions and compliance.
2020-09-25 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.